NCT05022901 2023-12-21An Open-Label Expanded Access Study of the Melphalan/Hepatic Delivery System (HDS) in Patients With Hepatic Dominant Ocular MelanomaDelcath Systems Inc.Phase 3 Unknown30 enrolled
NCT00000124 2006-06-02Collaborative Ocular Melanoma Study (COMS)National Eye Institute (NEI)Phase 3 Unknown